骨病回生丸治疗早期血瘀气滞型距骨坏死的疗效观察

Bone Disease Early Anabiosis Pill Treatment of Blood Stasis and Qi Curative Effect Observation of Osteonecrosis

目的:观察骨病回生丸治疗早期血瘀气滞型距骨坏死的临床疗效。方法:将64例72踝距骨坏死患者分为对照组34例和治疗组30例。对照组给予口服三七片和美洛昔康片,配合支具固定半年;治疗组不负重配合功能锻炼同时服用骨病回生丸。3个月为1个疗程,两组均治疗2个疗程,随访半年后判定疗效。结果:治疗组总有效率为96.6%,复发率3.3%;对照组总有效率70.5%,复发率35.2%,两组比较差异有统计学意义(P<0.05);X线摄片比较,治疗组总有效率93.3%,对照组为64.7%,两组比较差异有统计学意义(P<0.05)。结论:骨病回生丸治疗血瘀气滞型早期距骨坏死,具有提高疗效减少复发等优点,值得临床应用。

Objective To investigate the bone disease anabiosis pill treatment of blood stasis and qi early clinical curative effect of osteoneerosis. Methods 64 patients of 72 ankle osteoneerosis were divided into control group of 34 cases and treatment group 30 cases. Control group given oral Sanqi tablets and Meloxicam tablets, cooperate with a fixed half a year; Treatment with functional exercise group does not load at the same time taking bone disease pill retrogradation. Two groups as a course of 3 months, the two courses of treatment, follow- up after six months to determine efficacy. Results The treatment group total effective rate was 96. 6%, the recur- renee rate was 3.3% ; The control group total effective rate 70. 5% , the recurrence rate was 35.2% , comparing the two groups have significant difference （P 〈 0. 05 ）. X -ray radiography, the treatment group total effectiveness 93.3%, control group is 64. 7%, com- paring the two groups have significant difference （ P 〈0. 05 ）. Conclusion Bone disease anabiosis pill treatment of blood stasis and qi from early osteonecrosis, has the advantages of improving curative effect to reduce recurrence.